Literature DB >> 7717966

Deletions at the C-terminus of interferon gamma reduce RNA binding and activation of double-stranded-RNA cleavage by bovine seminal ribonuclease.

C H Schein1, M Haugg.   

Abstract

Recombinant interferon gamma (IFN-gamma) from three species activates the cleavage of double stranded (ds-) RNA by the dimeric RNAase isolated from bovine semen (BS-RNAase). Human and bovine IFN-gamma bind RNA tightly enough to inhibit cleavage by RNAase A [Schein, Haugg and Benner (1990) FEBS Lett. 270, 229-232]. Murine IFN-gamma and a proteolytic fragment of human IFN-gamma, both of which lack part of the positively charged C-terminus, bind RNA weakly and do not inhibit RNAase A. Their ability to activate BS-RNAase is proportional to their activity in the anti-viral assay. Two monoclonal antibodies that neutralize the anti-viral activity of human IFN-gamma inhibit the activation of BS-RNAase by both full-length and proteolysed human IFN-gamma. Our results demonstrate that the C-terminus of IFN-gamma contributes to RNA binding and activation of BS-RNAase, as well as to anti-viral activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717966      PMCID: PMC1136753          DOI: 10.1042/bj3070123

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

Review 1.  Interferons in cell growth and development.

Authors:  G Romeo; G Fiorucci; G B Rossi
Journal:  Trends Genet       Date:  1989-01       Impact factor: 11.639

Review 2.  Mechanisms of the antiviral action of interferons.

Authors:  C E Samuel
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1988

3.  Structure-function analysis of the human interferon gamma. The COOH terminus is not essential for functional activity.

Authors:  S K Luk; E Jay; F T Jay
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

4.  Differential activity of the 30-kD and the 100-kD forms of 2'-5'An synthetase induced by recombinant human interferon-alpha and interferon-gamma.

Authors:  M G Rosenblum; L Cheung; D Kessler
Journal:  J Interferon Res       Date:  1988-06

5.  Double-stranded ribonuclease coinduced with interferon.

Authors:  J M Meegan; P I Marcus
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

Review 6.  The return of pancreatic ribonucleases.

Authors:  S A Benner; R K Allemann
Journal:  Trends Biochem Sci       Date:  1989-10       Impact factor: 13.807

7.  Human interferon-gamma receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins.

Authors:  G Garotta; L Ozmen; M Fountoulakis; Z Dembic; A P van Loon; D Stüber
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

8.  Inhibition of in vitro angiogenesis by lymphotoxin and interferon-gamma.

Authors:  N Tsuruoka; M Sugiyama; Y Tawaragi; M Tsujimoto; T Nishihara; T Goto; N Sato
Journal:  Biochem Biophys Res Commun       Date:  1988-08-30       Impact factor: 3.575

9.  Primary structure of human placental ribonuclease inhibitor.

Authors:  F S Lee; E A Fox; H M Zhou; D J Strydom; B L Vallee
Journal:  Biochemistry       Date:  1988-11-15       Impact factor: 3.162

10.  Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes.

Authors:  D K St Clair; S M Rybak; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1988-09-20       Impact factor: 3.162

View more
  8 in total

Review 1.  Management of secondary peritonitis.

Authors:  D H Wittmann; M Schein; R E Condon
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

2.  Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.

Authors:  J Haelewyn; L Michiels; P Verhaert; M F Hoylaerts; R Witters; M De Ley
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 3.  Repurposing approved drugs on the pathway to novel therapies.

Authors:  Catherine H Schein
Journal:  Med Res Rev       Date:  2019-08-20       Impact factor: 12.944

Review 4.  Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses.

Authors:  Jiarui Li; Ester Boix
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model.

Authors:  RanLei Wei; Guillem Prats-Ejarque; Lu Lu; Maria Goetz; Gang Wang; Marc Torrent; Ester Boix
Journal:  Cell Mol Life Sci       Date:  2020-11-23       Impact factor: 9.261

6.  Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals.

Authors:  Catherine H Schein; David M Bowen; Jessica A Lewis; Kyung Choi; Aniko Paul; Gerbrand J van der Heden van Noort; Wenzhe Lu; Dmitri V Filippov
Journal:  BMC Bioinformatics       Date:  2012-08-24       Impact factor: 3.169

Review 7.  Immune Modulation by Human Secreted RNases at the Extracellular Space.

Authors:  Lu Lu; Jiarui Li; Mohammed Moussaoui; Ester Boix
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

Review 8.  Polyglutamine Repeats in Viruses.

Authors:  Catherine H Schein
Journal:  Mol Neurobiol       Date:  2018-09-04       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.